Toggle light / dark theme

Scientists Invent a Microscope That Can Safely Look Straight Through Your Skull

A team of scientists has now found a way to create a clear image from scattered infrared light emitted from a laser, even after it’s passed through a thick layer of bone.

‘Our microscope allows us to investigate fine internal structures deep within living tissues that cannot be resolved by any other means,’ said physicists Seokchan Yoon and Hojun Lee from Korea University.


Seeing what the heck is going on inside of us is useful for many aspects of modern medicine. But how to do this without slicing and dicing through barriers like flesh and bone to observe living intact tissues, like our brains, is a tricky thing to do.

Thick, inconsistent structures like bone will scatter light unpredictably, making it difficult to figure out what’s going on behind them. And the deeper you wish to see, the more scattered light obscures fine and fragile biological structure.

There are plenty of options for researchers who are keen to watch living tissues do their thing, using clever optical tricks to turn scattered photons moving at certain frequencies into an image. But by risking tissue damage or operating only at shallow depths, they all have drawbacks.

Frozen Bird Found in Siberia is 46,000 Years Old

Scientists have recovered DNA from a well-preserved horned lark found in Siberian permafrost. The results can contribute to explaining the evolution of sub species, as well as how the mammoth steppe transformed into tundra, forest and steppe biomes at the end of the last Ice Age.

In 2018, a well-preserved frozen bird was found in the ground in the Belaya Gora area of north-eastern Siberia. Researchers at the Centre for Palaeogenetics, a new research center at Stockholm University and the Swedish Museum of Natural History, haves studied the bird and the results are now published in the scientific journal Communications Biology. The analyses reveals that the bird is a 46,000-year-old female horned lark.

“Not only can we identify the bird as a horned lark. The genetic analysis also suggests that the bird belonged to a population that was a joint ancestor of two sub species of horned lark living today, one in Siberia, and one in the steppe in Mongolia. This helps us understand how the diversity of sub species evolves,” says Nicolas Dussex, researcher at the Department of Zoology at Stockholm University.

House passes historic bill to decriminalize cannabis

The proposal would end a federal ban on marijuana and create a pathway to expunge related criminal records.


As the cannabis industry continues to take root state by state, the House of Representatives voted in favor of removing marijuana from the federal Controlled Substances Act.

The House voted Friday on the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, which decriminalizes cannabis and clears the way to erase nonviolent federal marijuana convictions. The Senate is unlikely to approve the bill.

The MORE Act also creates pathways for ownership opportunities in the emerging industry, allows veterans to obtain medical cannabis recommendations from Veteran Affairs doctors, and establishes funding sources to reinvest in communities disproportionately affected by the war on drugs.

Dr. Leonard Hayflick — Cellular Senescence, Mycoplasmology, and Viral Vaccine Development

Dr leonard hayflick — father of cell senescence!


Dr. Leonard Hayflick, is Professor of Anatomy, University of California, San Francisco School of Medicine, where he has been part of the faculty since 1988.

Dr. Hayflick received his Ph.D. at the University of Pennsylvania, did a post-doctoral fellowship at the University of Texas under the tutelage of the renowned cell culturist Prof. Charles Pomerat, and then returned to Philadelphia, where he spent ten years as an Associate Member of the Wistar Institute, and two years as an Assistant Professor of Research Medicine at the University of Pennsylvania.

Dr. Hayflick is extremely well known for his research in a range of domains including cell biology, virus vaccine development, and mycoplasmology.

In 1962 he discovered that, contrary to what was believed since the turn of the century, cultured normal human and animal cells have a limited capacity to replicate. This phenomenon became known as “The Hayflick Limit” which became a discovery that overturned a dogma that existed since early in the twentieth century and focused attention on the cell as the fundamental location of age changes.

To study aging, scientists are looking to outer space

Scientists stress that the symptoms of space travel aren’t exactly the same as aging, and many changes reverse themselves once people return to Earth, but the comparisons are still useful. Spaceflight is an immersive experience that spares no traveler, while aging happens to every Earthling whether we like it or not. As such, life in space is a good model for understanding aging as a chronic process, Bailey says. The barren otherworld of outer space could even reveal new ways to protect ourselves against the process of growing old.


Space travel induces bodily changes that are remarkably similar to growing old, providing a unique way to boost medical research.

BioAge lands $90 million; gears up for clinical trials in 2021

Longevity biotech firm BioAge Labs is readying itself for clinical trials after raising a whopping $90 million Series C funding round. The company revealed it will be moving its lead platform-derived therapies, BGE-117 and BGE-175, into Phase 2 clinical trials in the first half of 2021.

Longevity. Technology: As the developer of an AI platform that maps the molecular pathways impacting human Longevity, we’ve followed developments at BioAge with great interest. With two compounds ready to enter the clinic next year, and more on the way, this company is fast-becoming one of Longevity’s most exciting prospects.

The new funds will be used to develop BioAge’s portfolio of therapies for increasing healthspan and lifespan, as well as to augment its AI platform, and further expand its capabilities to test drug candidates in predictive models of human diseases of aging.

/* */